España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Cartesian Therapeutics
RNAC
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$18.50
0.08
0.43%
Last update: 7:17 PM
15 minutes delayed
Get Report
Comment
Cartesian Therapeutics (RNAC) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cartesian Therapeutics (NASDAQ:RNAC) Stock
Cartesian Therapeutics Stock (NASDAQ: RNAC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 08, 2024
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Friday, July 05, 2024
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, July 03, 2024
HC Wainwright & Co. Maintains Buy on Cartesia...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Cartesian ...
Benzinga Newsdesk
Tuesday, July 02, 2024
Oppenheimer Downgrades Cartesian Therapeutics...
Benzinga Newsdesk
Cartesian's Autoimmune Disorder Candidate Hits Primary Goal In Mid-Stage Study, Announces Equity Raise Of $130M
Vandana Singh
Cartesian Therapeutics shares are trading low...
Benzinga Newsdesk
Cartesian Therapeutics Has Entered Into A Pri...
Benzinga Newsdesk
Cartesian Therapeutics Has Dosed The First Pa...
Benzinga Newsdesk
Cartesian Therapeutics Announced Topline Resu...
Benzinga Newsdesk
Monday, July 01, 2024
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Monday, June 24, 2024
Oppenheimer Reiterates Outperform on Cartesia...
Benzinga Newsdesk
Monday, June 17, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Friday, June 14, 2024
Oppenheimer Maintains Outperform on Cartesian...
Benzinga Newsdesk
Tuesday, June 04, 2024
Oppenheimer Initiates Coverage On Cartesian T...
Benzinga Newsdesk
Friday, May 24, 2024
Mizuho Initiates Coverage On Cartesian Therap...
Benzinga Newsdesk
Thursday, May 23, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Wednesday, May 22, 2024
Cartesian Therapeutics Secures FDA Regenerati...
Benzinga Newsdesk
Monday, May 13, 2024
What Makes Cartesian Therapeutics, Inc. a New Buy Stock
Zacks
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Wednesday, May 08, 2024
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Cartesian Therapeutics' Approximately $104.8M...
Benzinga Newsdesk
Cartesian Therapeutics Q1 2024 GAAP EPS $(10....
Benzinga Newsdesk
Tuesday, April 23, 2024
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Cartesia...
Benzinga Newsdesk
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Cartesian Therapeutics shares are trading hig...
Benzinga Newsdesk
Leerink Partners Initiates Coverage On Cartes...
Benzinga Newsdesk
Tuesday, April 16, 2024
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Monday, April 15, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Wednesday, April 10, 2024
Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
Vandana Singh
Needham Reiterates Buy on Cartesian Therapeut...
Benzinga Newsdesk
Tuesday, April 09, 2024
Needham Initiates Coverage On Cartesian Thera...
Benzinga Newsdesk
Friday, April 05, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Thursday, April 04, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Thursday, March 28, 2024
Cartesian Therapeutics shares are trading low...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Cartesian Therapeutics Announces Approval Of ...
Benzinga Newsdesk
Tuesday, March 19, 2024
LivePerson And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Monday, March 18, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Thursday, March 14, 2024
On March 8, Cartesian Therapeutics Received Notice From Audentes Therapeutics Of Termination Of License And Development Agreement, Dated Jan 8, 2023
Happy Mohamed
Monday, March 11, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Thursday, March 07, 2024
Cartesian Therapeutics Reports FY23 Net loss ...
Benzinga Newsdesk
Wednesday, March 06, 2024
HC Wainwright & Co. Reiterates Buy on Cartesi...
Benzinga Newsdesk
Tuesday, March 05, 2024
Cartesian Therapeutics Establishes New Corpor...
Benzinga Newsdesk
Monday, March 04, 2024
HC Wainwright & Co. Assumes Cartesian Therape...
Benzinga Newsdesk
Wednesday, January 10, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, January 08, 2024
Cartesian Therapeutics Highlights Progress an...
Benzinga Newsdesk
Cartesian Therapeutics Announces Long-Term Fo...
Benzinga Newsdesk
Friday, December 01, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch